SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

UBS cuts Syndax Pharmaceuticals target price to $31 from $33

Valid market news retained in the public archive without immediate LiveCast distribution.

SNDX

Related stories